Polymyalgia Rheumatica

What is polymyalgia rheumatica?

Polymyalgia rheumatica is an inflammatory condition that causes pain and stiffness in the muscles around the shoulders, neck, and hips. The name comes from Greek and Latin roots meaning “pain in many muscles,” which describes the main experience of the condition well. Despite the name, the problem is not actually in the muscles themselves. The inflammation mostly affects the tissues around the joints, including the bursae (small fluid-filled cushions near joints) and the linings of the shoulder and hip joints.

Many people who search for “what is polymyalgia rheumatica” are surprised to learn that it is one of the most common inflammatory rheumatic conditions in older adults. It almost always affects people over the age of 50, and it becomes more common with each decade after that, with the average age at diagnosis being around 70. It is rare in younger people. Women are affected more often than men, and the condition is seen more frequently in people of Northern European ancestry, although it can occur in any population.

Polymyalgia rheumatica is closely related to another condition called giant cell arteritis, which is inflammation of certain blood vessels, most often the arteries around the temples and scalp. A meaningful minority of people with polymyalgia rheumatica also develop giant cell arteritis, and doctors watch carefully for signs of it, because untreated giant cell arteritis can threaten eyesight. This connection is one of the main reasons the condition deserves prompt medical attention rather than being dismissed as ordinary aging or wear and tear.

The encouraging news is that polymyalgia rheumatica usually responds well to treatment, and many people eventually recover fully, although treatment often continues for a year or longer.

Symptoms of polymyalgia rheumatica

Polymyalgia rheumatica symptoms often appear relatively quickly, sometimes over a few days to a couple of weeks. Some people describe going to bed feeling normal and waking up stiff and aching. In other cases, the symptoms build more gradually. The pattern of symptoms is quite distinctive, which helps doctors recognize the condition.

Common symptoms include:

• Aching and stiffness in the shoulders — usually on both sides, and often the first area affected.
• Pain and stiffness in the neck, upper arms, hips, buttocks, and thighs — the pain tends to be symmetrical, meaning it affects both sides of the body.
• Morning stiffness lasting more than 45 minutes — stiffness after waking or after sitting still for a while (sometimes called gelling) is a hallmark of the condition.
• Difficulty with everyday movements — such as lifting the arms above shoulder height, getting out of bed, rising from a chair, dressing, or combing hair.
• Fatigue and a general feeling of being unwell — many people feel drained or run-down.
• Low-grade fever, loss of appetite, and unintended weight loss — these general symptoms occur in some people.
• Mild swelling or puffiness of the hands, wrists, or feet — less common, but possible.
• Low mood — ongoing pain, poor sleep, and loss of independence can affect emotional well-being.

In the early or untreated stage, symptoms are often at their worst first thing in the morning and after periods of rest, then ease somewhat with gentle activity as the day goes on. Once treatment begins, most people notice a dramatic improvement, often within days. During the later, treated stage of the illness, symptoms may flare up temporarily, particularly when medication doses are reduced, and then settle again once the dose is adjusted.

Because polymyalgia rheumatica is linked to giant cell arteritis, doctors also ask about a second set of symptoms: new headaches (often around the temples), tenderness of the scalp, pain in the jaw when chewing, and any changes in vision such as blurring, double vision, or brief loss of sight. These are not typical polymyalgia rheumatica symptoms on their own; if they appear, they need urgent medical assessment.

Causes and risk factors

The exact polymyalgia rheumatica causes are not fully understood. Researchers believe the condition arises from a combination of genetic susceptibility and environmental triggers that lead the immune system to produce inflammation in and around certain joints. It is considered an immune-mediated condition, meaning the body’s own defense system contributes to the inflammation, although it is not classified as a classic autoimmune disease in the way that, for example, lupus is.

Several factors are known to increase the likelihood of developing the condition:

• Age — the strongest risk factor. Polymyalgia rheumatica almost never occurs before age 50 and becomes more common with advancing age.
• Sex — women are affected roughly two to three times more often than men.
• Ancestry and geography — the condition is most common in people of Northern European descent, especially those with Scandinavian ancestry, though it occurs worldwide.
• Genetics — certain inherited variations in immune-system genes appear to increase susceptibility, and the condition occasionally clusters in families.
• Possible environmental triggers — some studies have noted seasonal patterns or associations with prior infections, suggesting that an infection may sometimes act as a trigger in a susceptible person, but no specific virus or bacterium has been proven to cause it.

It is important to understand what does not cause polymyalgia rheumatica. It is not caused by overuse, injury, or poor posture, and it is not a form of ordinary arthritis from wear and tear. It is also not contagious, so it cannot be passed from person to person.

Diagnosis

There is no single test that proves polymyalgia rheumatica. Polymyalgia rheumatica diagnosis is a clinical judgment: doctors combine the pattern of symptoms, a physical examination, blood tests, and sometimes imaging, while also ruling out other conditions that can look similar. This condition is typically diagnosed and managed by a rheumatologist, a physician who specializes in inflammatory and autoimmune diseases of the joints and connective tissues. In hospital groups such as Acibadem, this is handled by the rheumatology department.

Medical history and physical examination

Your doctor will ask when the symptoms started, where the pain is located, how long morning stiffness lasts, and how the symptoms affect daily activities. During the examination, the doctor typically checks the range of motion of the shoulders, neck, and hips, and looks for signs that might point to other diagnoses, such as swollen small joints (more typical of rheumatoid arthritis) or true muscle weakness (which suggests a muscle disease rather than polymyalgia rheumatica, where strength is usually preserved and movement is limited by pain).

Blood tests

Blood tests usually show evidence of inflammation. The two most commonly used markers are the erythrocyte sedimentation rate (ESR), a measure of how quickly red blood cells settle in a tube, and C-reactive protein (CRP), a protein the liver produces in response to inflammation. Both are often elevated in active polymyalgia rheumatica, although in a small proportion of people they can be normal or only mildly raised. Other blood tests help exclude look-alike conditions: for example, tests for rheumatoid arthritis antibodies, thyroid function tests, muscle enzyme tests, and general blood counts. Mild anemia (a low red blood cell count) is sometimes present.

Imaging

Imaging is not always required, but it can support the diagnosis. Ultrasound of the shoulders and hips may show inflammation of the bursae and tendon sheaths, which is a typical finding. In selected cases, magnetic resonance imaging (MRI) or other scans may be used, particularly when the picture is unclear. Classification criteria developed by international rheumatology organizations combine age, symptom pattern, blood markers, and ultrasound findings, and doctors may use these as a guide.

Response to treatment as a diagnostic clue

One distinctive feature of polymyalgia rheumatica is its rapid and often dramatic response to low doses of corticosteroid medication. If a person’s symptoms improve substantially within a few days of starting treatment, this supports the diagnosis. If there is little or no response, doctors usually reconsider and look for another explanation.

Checking for giant cell arteritis

Because of the close link between the two conditions, doctors routinely ask about headache, scalp tenderness, jaw pain with chewing, and visual symptoms at diagnosis and at follow-up visits. If giant cell arteritis is suspected, additional tests such as ultrasound of the temporal arteries or a small biopsy (tissue sample) of an artery may be arranged urgently.

Treatment options for polymyalgia rheumatica

The goal of polymyalgia rheumatica treatment is to relieve pain and stiffness, restore normal daily function, and prevent complications, while using the lowest effective dose of medication for the shortest necessary time. An overview of how this condition is managed is available on the polymyalgia rheumatica treatment page.

Corticosteroids: the standard treatment

The mainstay of treatment is a corticosteroid medication, most commonly prednisone or prednisolone, taken as a daily tablet. Corticosteroids are anti-inflammatory medicines that calm the immune activity driving the condition. Unlike many other inflammatory diseases, polymyalgia rheumatica usually responds to relatively low doses, and improvement is often striking within days.

Once symptoms are well controlled, the dose is reduced very gradually over many months, a process called tapering. Most people need treatment for at least a year, and in many cases longer; some need a small dose for two years or more. Tapering too quickly commonly leads to a flare of symptoms, so your doctor may adjust the pace based on how you feel and on blood test results. It is important not to stop corticosteroids suddenly, because the body needs time to resume its own natural steroid production.

Because longer-term corticosteroid use carries possible side effects — including bone thinning (osteoporosis), raised blood sugar, weight gain, high blood pressure, mood changes, cataracts, thinning skin, and increased infection risk — doctors monitor patients regularly. Preventive measures often include calcium and vitamin D, and in some cases medication to protect the bones, along with periodic checks of blood pressure, blood sugar, and bone density.

Steroid-sparing medications

If symptoms flare repeatedly during tapering, or if corticosteroid side effects become a concern, your doctor may add a second medication to reduce the steroid dose needed. Methotrexate, an immune-modulating medicine taken once a week, is the most commonly used option in this situation. In selected difficult cases, newer biologic medicines that block specific inflammatory signals may be considered by a rheumatologist. These decisions are individualized and made together with the patient.

Pain relievers and watchful waiting

Simple pain relievers and nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, generally provide only limited relief in polymyalgia rheumatica and are not a substitute for corticosteroids. A purely watch-and-wait approach without treatment is not usually recommended once the diagnosis is made, because untreated inflammation causes ongoing pain and disability; however, in very mild or uncertain cases a doctor may briefly observe symptoms while completing the diagnostic work-up.

Procedures and surgery

There is no surgical treatment for polymyalgia rheumatica itself, and procedures are rarely needed. Occasionally, a corticosteroid injection into a particularly painful shoulder or hip region may be used as an additional measure. Surgery plays no routine role in managing this condition.

Physical activity and supportive care

Gentle, regular exercise — such as walking, swimming, or stretching — helps maintain muscle strength, joint flexibility, and bone health, and it may reduce some medication side effects. A physical therapist can suggest a safe program. A balanced diet, adequate protein and calcium intake, not smoking, and limiting alcohol also support overall health during treatment.

Living with polymyalgia rheumatica and outlook

For most people, the long-term outlook is favorable. Polymyalgia rheumatica is usually a self-limiting condition, which means it tends to burn out over time. Many people are able to stop medication completely after one to two years, although some need longer courses, and relapses can occur, particularly in the first months after stopping treatment. A relapse does not mean the treatment has failed; it usually responds well to a temporary increase in the medication dose.

Day to day, most people find that once treatment is working, they can return to their normal activities, including work, hobbies, and exercise. Practical strategies that many patients find helpful include planning demanding tasks for later in the morning when stiffness has eased, pacing activities to manage fatigue, using warm showers or heat packs for stiffness, and keeping a simple diary of symptoms and medication doses to share at follow-up visits.

Regular medical follow-up matters throughout the course of the illness. Appointments typically include a review of symptoms, blood tests to track inflammation, monitoring for medication side effects, and screening questions for giant cell arteritis. Attending these visits and reporting new symptoms promptly gives the best chance of a smooth course. While no one can guarantee a particular outcome, the condition does not usually cause permanent joint damage, and with appropriate treatment most people regain their quality of life.

Frequently asked questions

What is polymyalgia rheumatica in simple terms?

Polymyalgia rheumatica is an inflammatory condition, seen almost only in adults over 50, that causes aching and pronounced morning stiffness in the shoulders, neck, and hips on both sides of the body. The inflammation affects the tissues around the joints rather than the muscles themselves, and it typically responds well to low doses of corticosteroid medication.

Can polymyalgia rheumatica heal or go away on its own?

The condition often does resolve eventually — in many cases within one to three years — but waiting without treatment usually means months or years of significant pain and disability, and it leaves the linked risk of giant cell arteritis unmonitored. For these reasons, doctors generally recommend treatment rather than watchful waiting once the diagnosis is confirmed.

How serious is polymyalgia rheumatica?

By itself, polymyalgia rheumatica is painful and disabling but does not usually damage the joints permanently or shorten life. The main serious concern is its association with giant cell arteritis, an inflammation of arteries that can threaten vision if untreated. This is why doctors monitor for warning signs such as new headache, jaw pain when chewing, and visual changes.

How long does polymyalgia rheumatica treatment last?

Treatment with corticosteroids typically continues for at least a year, and in many cases longer, because the dose must be reduced very gradually to avoid flares. Some people need a small maintenance dose for two years or more. Your doctor tailors the tapering schedule to your symptoms and blood test results, so the exact duration varies from person to person.

What is the difference between polymyalgia rheumatica and fibromyalgia?

Although both cause widespread pain, they are different conditions. Polymyalgia rheumatica is an inflammatory disease of older adults with raised inflammation markers in the blood and a strong response to corticosteroids. Fibromyalgia is a chronic pain condition that can occur at any age, does not raise inflammation markers, and does not respond to steroids. A doctor can usually distinguish them through history, examination, and blood tests.

Can polymyalgia rheumatica come back after treatment?

Yes, relapses are relatively common, especially when the medication dose is being lowered or shortly after treatment stops. A relapse usually causes the same aching and stiffness as before and typically settles quickly when the dose is temporarily increased. Recurrence months or years later is less common but possible, so it is sensible to seek medical review if familiar symptoms return.

Is exercise safe with polymyalgia rheumatica?

In general, yes. Gentle, regular activity such as walking, swimming, or stretching is usually encouraged once treatment has eased the pain, because it helps preserve strength, flexibility, and bone health during corticosteroid therapy. It is best to start slowly, avoid pushing through sharp pain, and ask your doctor or a physical therapist for guidance suited to your situation.

When to see a doctor

Make an appointment with a doctor if you are over 50 and develop new, persistent aching and stiffness in both shoulders or both hips, especially if morning stiffness lasts more than 45 minutes or interferes with dressing, rising from a chair, or lifting your arms. Early assessment allows other conditions to be ruled out and effective treatment to begin.

Seek urgent medical care — the same day — if you have been diagnosed with polymyalgia rheumatica, or have symptoms suggesting it, and you notice any of the following red-flag warning signs, which may indicate giant cell arteritis:

• A new or unusual headache, particularly around the temples or scalp.
• Tenderness of the scalp, for example when brushing your hair.
• Pain or tiredness in the jaw when chewing (jaw claudication).
• Any change in vision — blurring, double vision, a shadow or curtain over part of the vision, or sudden loss of sight in one eye, even if brief.
• High fever, drenching sweats, or rapid unexplained weight loss.

You should also contact your doctor promptly, though less urgently, if your symptoms flare while your medication dose is being reduced, if you develop possible medication side effects such as marked mood changes, easy bruising, or signs of infection, or if you feel unwell in a way you cannot explain while taking corticosteroids. Never stop corticosteroid tablets abruptly without medical advice, as this can be dangerous.